197 results on '"Badawy, Sherif M."'
Search Results
2. Highway Sustainability Factors: Holistic and Social Network Analyses
3. Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR study
4. Morphological, thermochemical, and rheomechanical evaluation of self-healing performance of asphalt binder modified with hybrid-structured phase change material capsules
5. Trends in volumes and survival after hematopoietic cell transplantation in racial/ethnic minorities
6. Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients
7. Intensive care risk and long-term outcomes in pediatric allogeneic hematopoietic cell transplant recipients
8. Impact of Race and Ethnicity on Outcomes After Umbilical Cord Blood Transplantation
9. Rates of severe neutropenia and infection risk in patients treated with deferiprone: 28 years of data
10. A multilevel mHealth intervention boosts adherence to hydroxyurea in individuals with sickle cell disease
11. Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis
12. Unfavorable transcriptome profiles and social disadvantage in hematopoietic cell transplantation: a CIBMTR analysis
13. International Roughness Index prediction for flexible pavements using novel machine learning techniques
14. An evaluation of patient-reported outcomes in sickle cell disease within a conceptual model
15. Impact of second primary malignancy postautologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis
16. Male-specific late effects in adult hematopoietic cell transplantation recipients: a systematic review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation
17. Comprehensive physico-chemical and rheo-mechanical characterization of multiple asphalt binder microphases to meet Egyptian conditions
18. Accounting for Preference Heterogeneity in Discrete-Choice Experiments: An ISPOR Special Interest Group Report
19. Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML
20. The ASH-ASPHO Choosing Wisely Campaign: 5 hematologic tests and treatments to question
21. Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia
22. Chronic Graft-versus-Host Disease, Nonrelapse Mortality, and Disease Relapse in Older versus Younger Adults Undergoing Matched Allogeneic Peripheral Blood Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis
23. Real‐world evidence: Long‐term safety of deferiprone in a large cohort of patients with sickle cell disease enrolled in a registry for up to 10 years.
24. Correction to: Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113AML patients
25. Severity of Chronic Graft-versus-Host Disease and Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancy
26. Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation
27. Adherence to immunosuppression in adult heart transplant recipients: A systematic review
28. Rheological and environmental evaluation of sulfur extended asphalt binders modified by high- and low-density polyethylene recycled waste
29. Racial and Socioeconomic Disparities in Long-Term Outcomes in ≥1 Year Allogeneic Hematopoietic Cell Transplantation Survivors: A CIBMTR Analysis
30. Mental health, pain and likelihood of opioid misuse among adults with sickle cell disease.
31. Expanded HCT-CI Definitions Capture Comorbidity Better for Younger Patients of Allogeneic HCT for Nonmalignant Diseases
32. Association of Chronic Graft-versus-Host Disease with Late Effects following Allogeneic Hematopoietic Cell Transplantation for Children with Hematologic Malignancy
33. The Impact of Pre-Apheresis Health Related Quality of Life on Peripheral Blood Progenitor Cell Yield and Donor's Health and Outcome: Secondary Analysis of Patient-Reported Outcome Data from the RDSafe and BMT CTN 0201 Clinical Trials
34. Health‐related quality of life with standard and curative therapies in thalassemia: A narrative literature review.
35. Intravenous fluid therapy and hospital outcomes for vaso‐occlusive episodes in children, adolescents, and young adults with sickle cell disease.
36. A cognitive–behavioral digital health intervention for sickle cell disease pain in adolescents: a randomized, controlled, multicenter trial.
37. Provider prescription of hydroxyurea in youth and adults with sickle cell disease: A review of prescription barriers and facilitators.
38. Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research
39. Post-Transplantation Cyclophosphamide Is Associated with an Increase in Non-Cytomegalovirus Herpesvirus Infections in Patients with Acute Leukemia and Myelodysplastic Syndrome
40. Correction to: Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation
41. Boosting Hot Mix Asphalt Dynamic Modulus Prediction Using Statistical and Machine Learning Regression Modeling Techniques.
42. Barriers to medication adherence in sickle cell disease: A comprehensive theory‐based evaluation using the COM‐B model.
43. Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United States
44. Evaluation of Waste Bottle Crates in the Form of Pyro-Oil and Fine Granules as Bitumen Rejuvenators and Modifiers.
45. Practical Guidance for the Use of Voxelotor in the Management of Sickle Cell Disease
46. Accuracy of online medical information: the case of social media in sickle cell disease.
47. Optimizing Shared Decision Making about Hydroxyurea in Young Children with Sickle Cell Anemia
48. Standardizing the Diagnostic and Therapeutic Approach to Newly Diagnosed Children with ITP: Prospective Data from the ITP Consortium of North America (ICON) Quality Improvement Initiative
49. Health-Related Quality of Life and Adherence to Hydroxyurea and Other Disease-Modifying Therapies among Individuals with Sickle Cell Disease: A Systematic Review
50. Mental Health Implications of the COVID-19 Pandemic Among Children and Adolescents: What Do We Know so Far?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.